CAS 1422435-39-9

2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylicAcidEthylEsterHydrochloride

CAS: 1422435-39-9

Formel: C₁₉H₂₂ClN₅O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 387.8633

Ref: IN-DA01E21H

Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)

CAS: 1422435-39-9

Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)

Reinheit: 98%

Molekulargewicht: 387.86g/mol

Ref: 54-OR1005372

Dabigatran Impurity 9 HCl

CAS: 1422435-39-9

Formel: C₁₉H₂₁N₅O₂·HCl

Farbe und Form: White To Off-White Solid

Molekulargewicht: 351.41 36.46

Ref: 4Z-D-5933

Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)

CAS: 1422435-39-9

Reinheit: 97%

Molekulargewicht: 387.87

Ref: 10-F988616

Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran ethyl ester hydrochloride

Kontrolliertes Produkt

CAS: 1422435-39-9

Applications 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride is derived from Dabigatran (D100090), which is a non-peptide, direct thrombin inhibior and anti-thrombotic.
References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)

Formel: C₁₉H₂₁N₅O₂·(HCl)

Farbe und Form: Neat

Molekulargewicht: 351.40 + (36.46)

Ref: TR-A611370